Reverse engineering of Onivyde? – Irinotecan liposome injection

已完结 10 由 Angel 发布于 2026/3/1 12:00:12

DOI:10.1016/j.ijpharm.2024.125000
作者：Jingyao Gan , Vivian Juang , Kaikai Wang , Ziyun Xia , Rose Ackermann , Minzhi Yu , Kristen Hong Dorsey , Winnie Lin , Xinye Wang , Yan Wang , Jing Li
文献类型：期刊论文
补充材料：只需要正文

Elsevier

Abstract：Onivyde® is an intravenous irinotecan liposomal injection approved by the FDA for the treatment of gemcitabine-refractory metastatic adenocarcinoma of the pancreas in combination with fluoro

应助信息

15小时前

Book学术机器人

e51d230a112d11f1a03b34735aa3bc31.pdf 已采纳

15小时前

Book学术机器人

2026/3/1 12:00:12 Book学术AI机器人已找到文献并上传

2026/3/1 12:00:12 Book学术AI机器人收到请求，开始寻找文献

2026/3/1 12:00:12 已向机器人发送请求

15小时前

Angel 发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:ElsevierThe drought-responsive wheat AP2/ERF transcription factor TaRAP2-13L and its interacting protein TaWRKY10 enhance drought tolerance in transgenic Arabidopsis and wheat (Triticum aestivum L.)